AGM 2020 Presentation

November 18, 2020August 16, 2022 Alterity Therapeutics

2020

Post navigation

Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
Alterity Therapeutics to Present at MST Financial Webinar
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar
Webcast Presentation on New Data from the bioMUSE Natural History Study

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

LinkedIn
Facebook
X

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

AGM 2020 Presentation

Related Posts

New hope in global fight against antibiotic resistant superbugs

Alterity Therapeutics meeting with US FDA provides development pathway for ATH434

Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting